At a rational concentration of 10 μM, nine hits satisfied the biological inhibition of both Tat and HIV-1, and two hits exhibiting dose-responsive inhibition of Tat activity were identified as novel inhibitory compounds against HIV-1 infection and replication with low cytotoxicity. This evidence concerns the gene TAT and HIV-1 infection.